Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States
Cancer survivors are a growing population, due in large part to the aging of the baby boomer generation and the related "silver tsunami" facing the U.S. health care system. Understanding the impact of a graying nation on cancer prevalence and comorbidity burden is critical in informing eff...
Uloženo v:
| Vydáno v: | Cancer epidemiology, biomarkers & prevention Ročník 25; číslo 7; s. 1029 |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.07.2016
|
| Témata: | |
| ISSN: | 1538-7755, 1538-7755 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Cancer survivors are a growing population, due in large part to the aging of the baby boomer generation and the related "silver tsunami" facing the U.S. health care system. Understanding the impact of a graying nation on cancer prevalence and comorbidity burden is critical in informing efforts to design and implement quality cancer care for this population.
Incidence and survival data from 1975 to 2011 were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program to estimate current cancer prevalence. SEER-Medicare claims data were used to estimate comorbidity burden. Prevalence projections were made using U.S. Census Bureau data and the Prevalence Incidence Approach Model, assuming constant future incidence and survival trends but dynamic projections of the U.S.
In 2016, there were an estimated 15.5 million cancer survivors living in the United States, 62% of whom were 65 years or older. The prevalent population is projected to grow to 26.1 million by 2040, and include 73% of survivors who are 65 years and older. Comorbidity burden was highest in the oldest survivors (those ≥85 years) and worst among lung cancer survivors.
Older adults, who often present with complex health needs, now constitute the majority of cancer survivors and will continue to dominate the survivor population over the next 24 years.
The oldest adults (i.e., those >75 years) should be priority populations in a pressing cancer control and prevention research agenda that includes expanding criteria for clinical trials to recruit more elderly participants and developing relevant supportive care interventions. Cancer Epidemiol Biomarkers Prev; 25(7); 1029-36. ©2016 AACR. |
|---|---|
| AbstractList | Cancer survivors are a growing population, due in large part to the aging of the baby boomer generation and the related "silver tsunami" facing the U.S. health care system. Understanding the impact of a graying nation on cancer prevalence and comorbidity burden is critical in informing efforts to design and implement quality cancer care for this population.
Incidence and survival data from 1975 to 2011 were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program to estimate current cancer prevalence. SEER-Medicare claims data were used to estimate comorbidity burden. Prevalence projections were made using U.S. Census Bureau data and the Prevalence Incidence Approach Model, assuming constant future incidence and survival trends but dynamic projections of the U.S.
In 2016, there were an estimated 15.5 million cancer survivors living in the United States, 62% of whom were 65 years or older. The prevalent population is projected to grow to 26.1 million by 2040, and include 73% of survivors who are 65 years and older. Comorbidity burden was highest in the oldest survivors (those ≥85 years) and worst among lung cancer survivors.
Older adults, who often present with complex health needs, now constitute the majority of cancer survivors and will continue to dominate the survivor population over the next 24 years.
The oldest adults (i.e., those >75 years) should be priority populations in a pressing cancer control and prevention research agenda that includes expanding criteria for clinical trials to recruit more elderly participants and developing relevant supportive care interventions. Cancer Epidemiol Biomarkers Prev; 25(7); 1029-36. ©2016 AACR. Cancer survivors are a growing population, due in large part to the aging of the baby boomer generation and the related "silver tsunami" facing the U.S. health care system. Understanding the impact of a graying nation on cancer prevalence and comorbidity burden is critical in informing efforts to design and implement quality cancer care for this population.BACKGROUNDCancer survivors are a growing population, due in large part to the aging of the baby boomer generation and the related "silver tsunami" facing the U.S. health care system. Understanding the impact of a graying nation on cancer prevalence and comorbidity burden is critical in informing efforts to design and implement quality cancer care for this population.Incidence and survival data from 1975 to 2011 were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program to estimate current cancer prevalence. SEER-Medicare claims data were used to estimate comorbidity burden. Prevalence projections were made using U.S. Census Bureau data and the Prevalence Incidence Approach Model, assuming constant future incidence and survival trends but dynamic projections of the U.S.METHODSIncidence and survival data from 1975 to 2011 were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program to estimate current cancer prevalence. SEER-Medicare claims data were used to estimate comorbidity burden. Prevalence projections were made using U.S. Census Bureau data and the Prevalence Incidence Approach Model, assuming constant future incidence and survival trends but dynamic projections of the U.S.In 2016, there were an estimated 15.5 million cancer survivors living in the United States, 62% of whom were 65 years or older. The prevalent population is projected to grow to 26.1 million by 2040, and include 73% of survivors who are 65 years and older. Comorbidity burden was highest in the oldest survivors (those ≥85 years) and worst among lung cancer survivors.RESULTSIn 2016, there were an estimated 15.5 million cancer survivors living in the United States, 62% of whom were 65 years or older. The prevalent population is projected to grow to 26.1 million by 2040, and include 73% of survivors who are 65 years and older. Comorbidity burden was highest in the oldest survivors (those ≥85 years) and worst among lung cancer survivors.Older adults, who often present with complex health needs, now constitute the majority of cancer survivors and will continue to dominate the survivor population over the next 24 years.CONCLUSIONSOlder adults, who often present with complex health needs, now constitute the majority of cancer survivors and will continue to dominate the survivor population over the next 24 years.The oldest adults (i.e., those >75 years) should be priority populations in a pressing cancer control and prevention research agenda that includes expanding criteria for clinical trials to recruit more elderly participants and developing relevant supportive care interventions. Cancer Epidemiol Biomarkers Prev; 25(7); 1029-36. ©2016 AACR.IMPACTThe oldest adults (i.e., those >75 years) should be priority populations in a pressing cancer control and prevention research agenda that includes expanding criteria for clinical trials to recruit more elderly participants and developing relevant supportive care interventions. Cancer Epidemiol Biomarkers Prev; 25(7); 1029-36. ©2016 AACR. |
| Author | Rowland, Julia H Bluethmann, Shirley M Mariotto, Angela B |
| Author_xml | – sequence: 1 givenname: Shirley M surname: Bluethmann fullname: Bluethmann, Shirley M email: shelley.bluethmann@nih.gov organization: Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland. Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland. shelley.bluethmann@nih.gov – sequence: 2 givenname: Angela B surname: Mariotto fullname: Mariotto, Angela B organization: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland – sequence: 3 givenname: Julia H surname: Rowland fullname: Rowland, Julia H organization: Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27371756$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1Lw0AQhhdR7If-BGXpyUvqfmS6jbdaqhYKLbQ9l00y0S3Jpu5uCj37xw1awdMMw_M-A2-PXNraIiF3nA05h_EjZwBRkoxgOFvNIz6KGJfygnQ5yHGkFMDlv71Det7vGWMqAbgmHaGk4gpGXfI1scFk5qCDse80fCAdrE15REc3vrG6MoMnunJ41CXaDOnG6T1moXYGPdU2p9O6ql1qchNO9LlxOVqqq7pVLcu8lUx1m3J03bijOdbOU2N_nmytCZjTddAB_Q25KnTp8fY8-2T7MttM36LF8nU-nSyig4jjEAkOYlzEqUqZZnFRiGyUMMlkFkOqhJYFaKXbo4QYUORpxhgiSBCQJVwxFH3y8Os9uPqzQR92lfEZlqW2WDd-x8eMx5JLzlv0_ow2aYX57uBMpd1p91ec-AapdnOD |
| ContentType | Journal Article |
| Copyright | 2016 American Association for Cancer Research. |
| Copyright_xml | – notice: 2016 American Association for Cancer Research. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1158/1055-9965.EPI-16-0133 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1538-7755 |
| ExternalDocumentID | 27371756 |
| Genre | Editorial Commentary |
| GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z99 CA999999 |
| GroupedDBID | --- .55 18M 29B 2FS 2WC 34G 39C 3O- 53G 5GY 5VS 6J9 AAFWJ ABOCM ACPRK ADBBV ADCOW AENEX AFHIN AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BR6 BTFSW C1A CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P FRP H13 H~9 IH2 KQ8 L7B NPM OK1 P2P PQQKQ QTD RCR RHI SJN UDS VH1 W8F WHG WOQ X7M ZXP 7X8 |
| ID | FETCH-LOGICAL-p244t-21528f4b7b0a04ff2c690303c45b72a3f5a7a2c63545e2dbc00ee53525c9170e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 835 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000380072700003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1538-7755 |
| IngestDate | Fri Jul 11 15:19:10 EDT 2025 Mon Jul 21 06:04:01 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | 2016 American Association for Cancer Research. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-p244t-21528f4b7b0a04ff2c690303c45b72a3f5a7a2c63545e2dbc00ee53525c9170e2 |
| Notes | SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1 |
| PMID | 27371756 |
| PQID | 1801431311 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1801431311 pubmed_primary_27371756 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-07-00 20160701 |
| PublicationDateYYYYMMDD | 2016-07-01 |
| PublicationDate_xml | – month: 07 year: 2016 text: 2016-07-00 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cancer epidemiology, biomarkers & prevention |
| PublicationTitleAlternate | Cancer Epidemiol Biomarkers Prev |
| PublicationYear | 2016 |
| SSID | ssj0007955 |
| Score | 2.671177 |
| Snippet | Cancer survivors are a growing population, due in large part to the aging of the baby boomer generation and the related "silver tsunami" facing the U.S. health... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1029 |
| SubjectTerms | Age Distribution Age Factors Aged Aged, 80 and over Cancer Survivors - statistics & numerical data Comorbidity Female Humans Incidence Male Neoplasms - epidemiology Population Surveillance Prevalence Risk SEER Program Sex Distribution Survivors - statistics & numerical data United States - epidemiology |
| Title | Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/27371756 https://www.proquest.com/docview/1801431311 |
| Volume | 25 |
| WOSCitedRecordID | wos000380072700003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAIsSFfSmbTMXV1FkcJ1xQhajgQKkESL1VtuOgcEhK0_ID_DgzTqqekJC45JAoSmQ_z7wZj-cRcsVVGmSRTlgac81ClXhMeYozk0kT-tryRBsnNiEHg3g0SoZNwq1qyioXNtEZ6rQ0mCPvetjmJMDmMLeTT4aqUbi72khorJIWPEoQ1XK07BYuE6d66ha1lEI0J3g8EXdRF5IB1xfX98NH5mFUjdq5v7FM52362__9zx2y1fBM2quBsUtWbLFHNp6anfR98t0rFvXUxTsFFkg7LzlWSdPXao4i9Z0biu2dlDuURMGlfbj8PgTWVBUpBTtSTnWeAomn9VEI6nSL6DPKftM7BNOUvszBEn2V04rmhftITXFpTXEPyFv__vXugTWCDGwCLGDGUAM3zkItNVc8zDLfQGwNPtCEQktfBZlQUsHNAGiZ9VNtOLcW-8cIA1Eht_4hWSvKwh4TGnkZYEHFQShtqIJAa2VTQIaA-C_xTdoml4vhHQPgcRdDFbacV-PlALfJUT1H40ndmWMMXAzCUxGd_OHtU7IJ5CeqS2_PSCuD5W7Pybr5muXV9MIhCa6D4dMPUFDTPg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anticipating+the+%22Silver+Tsunami%22%3A+Prevalence+Trajectories+and+Comorbidity+Burden+among+Older+Cancer+Survivors+in+the+United+States&rft.jtitle=Cancer+epidemiology%2C+biomarkers+%26+prevention&rft.au=Bluethmann%2C+Shirley+M&rft.au=Mariotto%2C+Angela+B&rft.au=Rowland%2C+Julia+H&rft.date=2016-07-01&rft.eissn=1538-7755&rft.volume=25&rft.issue=7&rft.spage=1029&rft_id=info:doi/10.1158%2F1055-9965.EPI-16-0133&rft_id=info%3Apmid%2F27371756&rft_id=info%3Apmid%2F27371756&rft.externalDocID=27371756 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7755&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7755&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7755&client=summon |